IP Verse

5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Major Depression

Patent No. EP4349407 (titled "5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Major Depression") was filed by GH Research Ireland on Feb 24, 2020. The application was issued on Apr 9, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJan 9, 2026CMS CAMERON MCKENNA NABARRO OLSWANG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4349407

GH RESEARCH IRELAND
Application Number
EP24157425A
Filing Date
Feb 24, 2020
Status
Granted And Under Opposition
Mar 7, 2025
Publication Date
Apr 9, 2025
External Links
Slate, Register , Google Patents